Table 2.
Histologic subtype and stage distribution.
| Variable | Overall (n = 30) | Adequately Screened (n = 15) | Inadequately Screened (n = 15) | US Population ⁎ | P value |
|---|---|---|---|---|---|
| Histologic subtype | 1.000 | ||||
| Squamous cell | 24 (80.0%) | 12 (80.0%) | 12 (80.0%) | ||
| Adenocarcinoma | 6 (20.0%) | 3 (20.0%) | 3 (20.0%) | ||
| Diagnostic stage | 0.5572 | ||||
| IA1 | 0 | 0 | 0 | ||
| IA2 | 0 | 0 | 0 | ||
| IB1 | 5(16.7%) | 4(26.7%) | 1(6.7%) | ||
| IB2 | 4 (13.3%) | 3(20.0%) | 1(6.7%) | ||
| IIA | 2(6.7%) | 1(6.7%) | 1(6.7%) | ||
| IIB | 8 (26.7%) | 4(26.7%) | 4(26.7%) | ||
| IIIA | 1 (3.3%) | 0 | 1(6.7%) | ||
| IIIB | 6 (20.0%) | 2(13.3%) | 4(26.7%) | ||
| IVA | 2 (6.7%) | 1(6.7%) | 1(6.7%) | ||
| IVB | 2 (6.7%) | 0 | 2(13.3%) | ||
| Diagnostic stage grouping | 0.1934 | ||||
| Localized | 9 (30.0%) | 7 (46.7%) | 2 (13.3%) | 46% | |
| Regional | 17 (56.7%) | 7 (46.7%) | 10 (66.7%) | 36% | |
| Distant | 4 (13.3%) | 1 (6.7%) | 3 (20.0%) | 14% | |
| Unknown | 4% |
⁎
Based on SEER data (5).